click below
click below
Normal Size Small Size show me how
Antibiotics
Drug | Family | Mechanism |
---|---|---|
penicillin V | -cillin, Beta-Lactams, Natural Penicillins, Narrow G+ coverage, Limited G- activity, Renally excreted unchanged | Irreversible inhibition of PBPs that assist in formation and remodeling of bacterial cell wall. Inhibition leads to decreased cell wall synthesis and repair. Lysis due to osmotic pressure. |
amoxicillin | am- -cillin, Beta-Lactams, Aminopenicillins, Narrow G+ coverage, Enhanced G- activity, Renally excreted unchanged | Irreversible inhibition of PBPs that assist in formation and remodeling of bacterial cell wall. Inhibition leads to decreased cell wall synthesis and repair. Lysis due to osmotic pressure. |
ampicillin | am- -cillin, Beta-Lactams, Aminopenicillins, Narrow G+ coverage, Enhanced G- activity, Renally excreted unchanged | Irreversible inhibition of PBPs that assist in formation and remodeling of bacterial cell wall. Inhibition leads to decreased cell wall synthesis and repair. Lysis due to osmotic pressure. |
nafcillin | -cillin, Beta-Lactams, Antistaphs, Narrow MSSA, Renally excreted unchanged | Irreversible inhibition of PBPs that assist in formation and remodeling of bacterial cell wall. Inhibition leads to decreased cell wall synthesis and repair. Lysis due to osmotic pressure. |
piperacillin | -cillin, Beta-Lactams, Ureidopenicillins, Narrow G+ coverage, Greater G- activity, Renally excreted unchanged | Irreversible inhibition of PBPs that assist in formation and remodeling of bacterial cell wall. Inhibition leads to decreased cell wall synthesis and repair. Lysis due to osmotic pressure. |
imipenem/cilastatin | no root, Beta-Lactams, Carbapenams, Deactivated in kidney but more can be recovered when administered with cilastatin, Not orally active, Gram negative bacilli, anaerobes, and S. aureus | Irreversible inhibition of PBPs that assist in formation and remodeling of bacterial cell wall. Inhibition leads to decreased cell wall synthesis and repair. Lysis due to osmotic pressure. |
cefazolin | cef-, Beta-Lactams, Cephalosporins 1st Gen, G+ cocci, Limited G-, Renally excreted unchanged | Irreversible inhibition of PBPs that assist in formation and remodeling of bacterial cell wall. Inhibition leads to decreased cell wall synthesis and repair. Lysis due to osmotic pressure. |
cefotaxime | cef-, Beta-Lactams, Cephalosporins 3rd Gen, Better G- Renally excreted unchanged | Irreversible inhibition of PBPs that assist in formation and remodeling of bacterial cell wall. Inhibition leads to decreased cell wall synthesis and repair. Lysis due to osmotic pressure. |
ceftriaxone | cef-, Beta-Lactams, Cephalosporins 3rd Gen, Better G- Renally excreted unchanged | Irreversible inhibition of PBPs that assist in formation and remodeling of bacterial cell wall. Inhibition leads to decreased cell wall synthesis and repair. Lysis due to osmotic pressure. |
cephalexin | cef-, Beta-Lactams, Cephalosporins 1st Gen, G+ cocci, Limited G-, Renally excreted unchanged | Irreversible inhibition of PBPs that assist in formation and remodeling of bacterial cell wall. Inhibition leads to decreased cell wall synthesis and repair. Lysis due to osmotic pressure. |
aztreonam | no root, Beta-Lactams, Monobactams, Exclusively used against severe gram negative infections, esp those in the hospital. | Irreversible inhibition of PBPs that assist in formation and remodeling of bacterial cell wall. Inhibition leads to decreased cell wall synthesis and repair. Lysis due to osmotic pressure. |
amoxicillin/clavulanic acid | am- -cillin, Beta-Lactams, Aminopenicillins, Narrow G+ coverage, Enhanced G- activity, Renally excreted unchanged, Clavuanic acid works to inhibit beta-lactamase | Irreversible inhibition of PBPs that assist in formation and remodeling of bacterial cell wall. Inhibition leads to decreased cell wall synthesis and repair. Lysis due to osmotic pressure. |
piperacillin/tazobactam | -cillin, Beta-Lactams, Ureidopenicillins, Narrow G+ coverage, Greater G- activity, Renally excreted unchanged | Irreversible inhibition of PBPs that assist in formation and remodeling of bacterial cell wall. Inhibition leads to decreased cell wall synthesis and repair. Lysis due to osmotic pressure. |
ciprofloxacin | -floxacin, Fluoroquinolones 2nd Gen, Generally well-tolerated, damage to growing cartilage, possible tendonitis | Inhibit DNA gyrase in G- (relieves positive supercoiling) and/or topoisomerase IV in G+ (Involved in untying daughter DNA formed during replication). Leaves cell's DNA inaccessible and leads to cell death. |
levofloxacin | -floxacin, Fluoroquinolones 3rd Gen, Generally well-tolerated, damage to growing cartilage, possible tendonitis | Inhibit DNA gyrase in G- (relieves positive supercoiling) and/or topoisomerase IV in G+ (Involved in untying daughter DNA formed during replication). Leaves cell's DNA inaccessible and leads to cell death. |
nitrofurantoin | no root, Quinolones, Generally well-tolerated, damage to growing cartilage, possible tendonitis | Produce reactive oxygen species in bacteria. |
sulfamethoxazole | sulfa-, Sulfonamide, Bacteriostatic | Inhibits dihydropteroate synthase and give a false metabolite. |
Trimethoprim / sulfamethoxazole (cotrimoxazole) | no root, Combination makes both bactericidal | Inhibits dihydrofolate synthase (Tmp) and dihydropteroate synthase (Sulfa). |
azithromycin | -omycin (for synthesis inhibitors), Protein synthesis inhibitors, Macrolides | Bind 23S rRNA at E site, halting translation |
clarithromycin | -omycin (for synthesis inhibitors), Protein synthesis inhibitors, Macrolides | Bind 23S rRNA at E site, halting translation |
erythromycin | -omycin (for synthesis inhibitors), Protein synthesis inhibitors, Macrolides | Bind 23S rRNA at E site, halting translation |
fidaxomicin | -omycin (for synthesis inhibitors), Protein synthesis inhibitors, Macrolides | Bind 23S rRNA at E site, halting translation |
doxycycline | Protein synthesis inhibitors | |
chloramphenicol | Protein synthesis inhibitors, Bacteriostatic | |
clindamycin | -omycin (for synthesis inhibitors), Protein synthesis inhibitors, Bacteriostatic | |
gentamicin | -omycin (for synthesis inhibitors), Protein synthesis inhibitors, Aminoglycosides | Bind 16S ribosomal RNA portion of the bacterial ribosome. Result in blocking of initiation of translation, blocking of further translation once started, and induction of a conformation change that results in the incorporation of incorrect amino acid. |
streptomycin | -omycin (for synthesis inhibitors), Protein synthesis inhibitors, Aminoglycosides | Bind 16S ribosomal RNA portion of the bacterial ribosome. Result in blocking of initiation of translation, blocking of further translation once started, and induction of a conformation change that results in the incorporation of incorrect amino acid. |
neomycin | -omycin (for synthesis inhibitors), Protein synthesis inhibitors, Aminoglycosides | Bind 16S ribosomal RNA portion of the bacterial ribosome. Result in blocking of initiation of translation, blocking of further translation once started, and induction of a conformation change that results in the incorporation of incorrect amino acid. |
tobramycin | -omycin (for synthesis inhibitors), Protein synthesis inhibitors, Aminoglycosides | Bind 16S ribosomal RNA portion of the bacterial ribosome. Result in blocking of initiation of translation, blocking of further translation once started, and induction of a conformation change that results in the incorporation of incorrect amino acid. |
linezolid | Protein synthesis inhibitors | |
isoniazid | Antimycobacterial, Used for TB, leprosy | Inhibition of mycolic acid synthesis, bactericidal for growing forms, bacteriostatic for resting forms. |
rifampin | Antimycobacterial, Used for TB, leprosy | Inhibition of DNA-dependent RNA polymerase, blocking transcription |
dapsone | Antimycobacterial, Used for leprosy | Antifolate, similar to sulfa drugs. |
Vancomycin | Glycopeptides, Exclusively G+ bacteria (MRSA, MRSE, VRE), No use against G-, Only IV | Inhibits bacterial cell wall biosynthesis, binds to a peptide-lined cleft in peptidoglycan. |
Metronidazole | Parasitic and bacterial infections. ESP c. diff. | Unknown, but thought to produce reactive oxygen species. |
Polymyxin B | Cell wall disrupter, Limited to drug-resistant G- infections | Surface-active amphipathic molecules that disrupt plasma membrane |
penicillin G | -cillin, Beta-Lactams, Natural Penicillins, Narrow G+ coverage, Limited G- activity, Renally excreted unchanged | Irreversible inhibition of PBPs that assist in formation and remodeling of bacterial cell wall. Inhibition leads to decreased cell wall synthesis and repair. Lysis due to osmotic pressure. |